Dr. Stuart Winter, M.D

NPI: 1982798468
Total Payments
$25,500
2024 Payments
$9,085
Companies
2
Transactions
11

Payment Breakdown by Category

Consulting$22,804 (89.4%)
Other$2,480 (9.7%)
Food & Beverage$147.01 (0.6%)
Travel$69.02 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $22,804 8 89.4%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,480 1 9.7%
Food and Beverage $147.01 1 0.6%
Travel and Lodging $69.02 1 0.3%

Top Paying Companies

Company Total Records Latest Year
Jazz Pharmaceuticals Inc. $16,415 9 $0 (2023)
Amgen Inc. $9,085 2 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $9,085 2 Amgen Inc. ($9,085)
2023 $2,627 2 Jazz Pharmaceuticals Inc. ($2,627)
2019 $962.50 1 JAZZ PHARMACEUTICALS INC. ($962.50)
2018 $9,225 4 Jazz Pharmaceuticals Inc. ($9,225)
2017 $3,600 2 Jazz Pharmaceuticals Inc. ($3,600)

All Payment Transactions

11 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
05/31/2024 Amgen Inc. Blincyto (Biological) Consulting Fee Cash or cash equivalent $9,016.00 General
Category: Oncology
05/31/2024 Amgen Inc. Blincyto (Biological) Travel and Lodging Cash or cash equivalent $69.02 General
Category: Oncology
12/18/2023 Jazz Pharmaceuticals Inc. RYLAZE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,480.00 General
Category: HEMATOLOGY/ONCOLOGY
12/10/2023 Jazz Pharmaceuticals Inc. Food and Beverage In-kind items and services $147.01 General
04/04/2019 JAZZ PHARMACEUTICALS INC. ERWINAZE (Drug) Consulting Fee Cash or cash equivalent $962.50 General
Category: ONCOLOGY
11/08/2018 Jazz Pharmaceuticals Inc. Erwinaze (Drug) Consulting Fee Cash or cash equivalent $1,100.00 General
Category: Oncology
08/30/2018 Jazz Pharmaceuticals Inc. Erwinaze (Drug) Consulting Fee Cash or cash equivalent $5,775.00 General
Category: Oncology
06/07/2018 Jazz Pharmaceuticals Inc. Erwinaze (Drug) Consulting Fee Cash or cash equivalent $550.00 General
Category: Oncology
02/22/2018 Jazz Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $1,800.00 General
08/24/2017 Jazz Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $1,200.00 General
07/06/2017 Jazz Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $2,400.00 General

About Dr. Stuart Winter, M.D

Dr. Stuart Winter, M.D is a Pediatric Hematology-Oncology healthcare provider based in Albuquerque, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982798468.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Winter, M.D has received a total of $25,500 in payments from pharmaceutical and medical device companies, with $9,085 received in 2024. These payments were reported across 11 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($22,804).

Practice Information

  • Specialty Pediatric Hematology-Oncology
  • Other Specialties Pediatric Hematology-Oncology
  • Location Albuquerque, NM
  • Active Since 10/02/2006
  • Last Updated 01/06/2026
  • Taxonomy Code 2080P0207X
  • Entity Type Individual
  • NPI Number 1982798468

Products in Payments

  • Blincyto (Biological) $9,085
  • Erwinaze (Drug) $7,425
  • RYLAZE (Drug) $2,480
  • ERWINAZE (Drug) $962.50

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Hematology-Oncology Doctors in Albuquerque